U.S. FDA accepts application for Indivior's new schizophrenia drug

(Reuters) - U.S. Food and Drug Administration (FDA) accepted Indivior's application for its new schizophrenia treatment, the British drugmaker said on Tuesday, boosting hopes of marketing the drug in the country.